Chutes & Ladders—Biopharma veteran takes her CEO Cue Read more →

Odyssey voyages to Nasdaq with $304M IPO to fund autoimmune, inflammatory pipeline Read more →

Banyan BioInnovations puts down roots with $100M, Icon partnership Read more →